Impact of post-challenge hyperglycemia on clinical outcomes in japanese patients with stable angina undergoing percutaneous coronary intervention

Table 2 Glucometabolic state and lipid profile of the 3 groups

	DM (n=452)	PH (n=236)	NGT (n=140)	P value
Glucometabolic state
FPG, mg/dl	140.0 (111.2-194.0)*†	94.0 (88.0-101.7)†	86.0 (82.2-91.0)	<0.001
2-h PG, mg/dl	-	189.5 (161.0-224.2)†	116.0 (97.0-128.0)	<0.001
HbA1c, %	7.3 (6.8-8.3)*†	6.0 (5.8-6.3)†	5.8 (5.6-6.0)	<0.001
Lipid profile, mg/dl
Total choresterol	181 (156–207.7)	176 (155.2-196.7)	177.5 (158.2-203.7)	0.37
Triglyceride	131.5 (94–194)	132 (101.2-178.7)	117 (91.5-162)	0.12
HDL-C	47 (40–55)	44 (37–51)†‡	47.5 (39–57)	0.001
LDL-C	104 (85–126.7)	106.5 (88.2-126)	105.5 (88–125.7)	0.64

Values are expressed as medians (interquartile range). *P <0.05 vs. PH; †P <0.05 vs. NGT; and ‡P <0.05 vs. DM.
FPG, fasting plasma glucose; HbA1c, hemoglobin A1c; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; PG, plasma glucose. Other abbreviations as in Table 1.

ISSN: 1475-2840